Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase.

Dying-back degeneration of motor neuron axons represents an established feature of familial amyotrophic lateral sclerosis (FALS) associated with superoxide dismutase 1 (SOD1) mutations, but axon-autonomous effects of pathogenic SOD1 remained undefined. Characteristics of motor neurons affected in FA...

Full description

Bibliographic Details
Main Authors: Gerardo A Morfini, Daryl A Bosco, Hannah Brown, Rodolfo Gatto, Agnieszka Kaminska, Yuyu Song, Linda Molla, Lisa Baker, M Natalia Marangoni, Sarah Berth, Ehsan Tavassoli, Carolina Bagnato, Ashutosh Tiwari, Lawrence J Hayward, Gustavo F Pigino, D Martin Watterson, Chun-Fang Huang, Gary Banker, Robert H Brown, Scott T Brady
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3680447?pdf=render
_version_ 1819326989570408448
author Gerardo A Morfini
Daryl A Bosco
Hannah Brown
Rodolfo Gatto
Agnieszka Kaminska
Yuyu Song
Linda Molla
Lisa Baker
M Natalia Marangoni
Sarah Berth
Ehsan Tavassoli
Carolina Bagnato
Ashutosh Tiwari
Lawrence J Hayward
Gustavo F Pigino
D Martin Watterson
Chun-Fang Huang
Gary Banker
Robert H Brown
Scott T Brady
author_facet Gerardo A Morfini
Daryl A Bosco
Hannah Brown
Rodolfo Gatto
Agnieszka Kaminska
Yuyu Song
Linda Molla
Lisa Baker
M Natalia Marangoni
Sarah Berth
Ehsan Tavassoli
Carolina Bagnato
Ashutosh Tiwari
Lawrence J Hayward
Gustavo F Pigino
D Martin Watterson
Chun-Fang Huang
Gary Banker
Robert H Brown
Scott T Brady
author_sort Gerardo A Morfini
collection DOAJ
description Dying-back degeneration of motor neuron axons represents an established feature of familial amyotrophic lateral sclerosis (FALS) associated with superoxide dismutase 1 (SOD1) mutations, but axon-autonomous effects of pathogenic SOD1 remained undefined. Characteristics of motor neurons affected in FALS include abnormal kinase activation, aberrant neurofilament phosphorylation, and fast axonal transport (FAT) deficits, but functional relationships among these pathogenic events were unclear. Experiments in isolated squid axoplasm reveal that FALS-related SOD1 mutant polypeptides inhibit FAT through a mechanism involving a p38 mitogen activated protein kinase pathway. Mutant SOD1 activated neuronal p38 in mouse spinal cord, neuroblastoma cells and squid axoplasm. Active p38 MAP kinase phosphorylated kinesin-1, and this phosphorylation event inhibited kinesin-1. Finally, vesicle motility assays revealed previously unrecognized, isoform-specific effects of p38 on FAT. Axon-autonomous activation of the p38 pathway represents a novel gain of toxic function for FALS-linked SOD1 proteins consistent with the dying-back pattern of neurodegeneration characteristic of ALS.
first_indexed 2024-12-24T13:03:43Z
format Article
id doaj.art-c19ff8f0c04447fd912d1b2f9f9ca560
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-24T13:03:43Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-c19ff8f0c04447fd912d1b2f9f9ca5602022-12-21T16:54:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0186e6523510.1371/journal.pone.0065235Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase.Gerardo A MorfiniDaryl A BoscoHannah BrownRodolfo GattoAgnieszka KaminskaYuyu SongLinda MollaLisa BakerM Natalia MarangoniSarah BerthEhsan TavassoliCarolina BagnatoAshutosh TiwariLawrence J HaywardGustavo F PiginoD Martin WattersonChun-Fang HuangGary BankerRobert H BrownScott T BradyDying-back degeneration of motor neuron axons represents an established feature of familial amyotrophic lateral sclerosis (FALS) associated with superoxide dismutase 1 (SOD1) mutations, but axon-autonomous effects of pathogenic SOD1 remained undefined. Characteristics of motor neurons affected in FALS include abnormal kinase activation, aberrant neurofilament phosphorylation, and fast axonal transport (FAT) deficits, but functional relationships among these pathogenic events were unclear. Experiments in isolated squid axoplasm reveal that FALS-related SOD1 mutant polypeptides inhibit FAT through a mechanism involving a p38 mitogen activated protein kinase pathway. Mutant SOD1 activated neuronal p38 in mouse spinal cord, neuroblastoma cells and squid axoplasm. Active p38 MAP kinase phosphorylated kinesin-1, and this phosphorylation event inhibited kinesin-1. Finally, vesicle motility assays revealed previously unrecognized, isoform-specific effects of p38 on FAT. Axon-autonomous activation of the p38 pathway represents a novel gain of toxic function for FALS-linked SOD1 proteins consistent with the dying-back pattern of neurodegeneration characteristic of ALS.http://europepmc.org/articles/PMC3680447?pdf=render
spellingShingle Gerardo A Morfini
Daryl A Bosco
Hannah Brown
Rodolfo Gatto
Agnieszka Kaminska
Yuyu Song
Linda Molla
Lisa Baker
M Natalia Marangoni
Sarah Berth
Ehsan Tavassoli
Carolina Bagnato
Ashutosh Tiwari
Lawrence J Hayward
Gustavo F Pigino
D Martin Watterson
Chun-Fang Huang
Gary Banker
Robert H Brown
Scott T Brady
Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase.
PLoS ONE
title Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase.
title_full Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase.
title_fullStr Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase.
title_full_unstemmed Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase.
title_short Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase.
title_sort inhibition of fast axonal transport by pathogenic sod1 involves activation of p38 map kinase
url http://europepmc.org/articles/PMC3680447?pdf=render
work_keys_str_mv AT gerardoamorfini inhibitionoffastaxonaltransportbypathogenicsod1involvesactivationofp38mapkinase
AT darylabosco inhibitionoffastaxonaltransportbypathogenicsod1involvesactivationofp38mapkinase
AT hannahbrown inhibitionoffastaxonaltransportbypathogenicsod1involvesactivationofp38mapkinase
AT rodolfogatto inhibitionoffastaxonaltransportbypathogenicsod1involvesactivationofp38mapkinase
AT agnieszkakaminska inhibitionoffastaxonaltransportbypathogenicsod1involvesactivationofp38mapkinase
AT yuyusong inhibitionoffastaxonaltransportbypathogenicsod1involvesactivationofp38mapkinase
AT lindamolla inhibitionoffastaxonaltransportbypathogenicsod1involvesactivationofp38mapkinase
AT lisabaker inhibitionoffastaxonaltransportbypathogenicsod1involvesactivationofp38mapkinase
AT mnataliamarangoni inhibitionoffastaxonaltransportbypathogenicsod1involvesactivationofp38mapkinase
AT sarahberth inhibitionoffastaxonaltransportbypathogenicsod1involvesactivationofp38mapkinase
AT ehsantavassoli inhibitionoffastaxonaltransportbypathogenicsod1involvesactivationofp38mapkinase
AT carolinabagnato inhibitionoffastaxonaltransportbypathogenicsod1involvesactivationofp38mapkinase
AT ashutoshtiwari inhibitionoffastaxonaltransportbypathogenicsod1involvesactivationofp38mapkinase
AT lawrencejhayward inhibitionoffastaxonaltransportbypathogenicsod1involvesactivationofp38mapkinase
AT gustavofpigino inhibitionoffastaxonaltransportbypathogenicsod1involvesactivationofp38mapkinase
AT dmartinwatterson inhibitionoffastaxonaltransportbypathogenicsod1involvesactivationofp38mapkinase
AT chunfanghuang inhibitionoffastaxonaltransportbypathogenicsod1involvesactivationofp38mapkinase
AT garybanker inhibitionoffastaxonaltransportbypathogenicsod1involvesactivationofp38mapkinase
AT roberthbrown inhibitionoffastaxonaltransportbypathogenicsod1involvesactivationofp38mapkinase
AT scotttbrady inhibitionoffastaxonaltransportbypathogenicsod1involvesactivationofp38mapkinase